Results 51 to 60 of about 12,531 (249)
Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
Biomedicines, 2022 Levosimendan, a calcium sensitizer, has an organ protective profile through the inhibition of inflammatory mediators and cytokines in critical conditions, such as heart failure, ischemia-reperfusion injury, and sepsis. The survival effect of levosimendan
Tatsuma Sakaguchi +7 more
doaj +1 more source
Levosimendan: The current situation and new prospects
Revista Portuguesa de Cardiologia, 2014 Levosimendan is a pyridazinone-dinitrile derivative with positive inotropic and vasodilatory effects that has beneficial effects on myocardial performance.In previous randomized studies levosimendan improved hemodynamics and clinical course, but its ...
Nuno Moreno +5 more
doaj +1 more source
Levosimendan: Perpetuum mobile? [PDF]
European Heart Journal, 2007 We read with great interest the well-written review about levosimendan by De Luca et al. 1 Levosimendan is certainly an interesting drug that appears to deliver favourable effects in patients with acute heart failure. Numerous studies have demonstrated the positive inotropic …
Stefan, Agewall, Dan, Atar
openaire +2 more sources
Heart failure : studies of prognosis and advanced therapy [PDF]
, 2017 Background Heart failure (HF) is a major health problem affecting 2-3% of the Western population. The clinical syndrome of HF is associated with reduced (HFrEF) or preserved (HFpEF) ejection fraction.
Thorvaldsen, Tonje
core +1 more source
Journal of Cardiothoracic Surgery, 2022 Objective Investigate the safety and efficacy of preoperative levosimendan in patients undergoing left ventricular assist device (LVAD) implantation.
Amitai Segev +9 more
doaj +1 more source
Clinical Case Reports, Volume 13, Issue 12, December 2025.Mitral anterolateral papillary muscle rupture with partial valve body prolapse and severe mitral regurgitation after acute myocardial infarction (ultrasound schematic). ABSTRACT Due to dual blood supply, ischemic mitral anterolateral papillary muscle rupture is less common than that of posteromedial papillary muscle and is rare in acute myocardial ...
Zeyan Liu +4 more
wiley +1 more source
Critical Care, 2017 Background Small trials suggest that levosimendan is associated with a favorable outcome in patients undergoing cardiac surgery. However, recently published larger-scale trials did not provide evidence for a similar benefit from levosimendan.
Qi-Hong Chen +5 more
doaj +1 more source
Current state of knowledge on Takotsubo Syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology [PDF]
, 2015 Takotsubo syndrome is an acute reversible heart failure syndrome that is increasingly recognized in modern cardiology practice. This Position Statement from the European Society of Cardiology Heart Failure Association provides a comprehensive review of ...
Akashi, YJ +13 more
core +2 more sources
ESC Heart Failure, Volume 12, Issue 6, Page 4160-4170, December 2025.Abstract Aims Despite therapeutic advancements, the prognosis of heart failure (HF) remains poor, with high rates of mortality and readmission, particularly following a HF exacerbation. This study aimed to evaluate the effects of a nurse‐coordinated multidisciplinary comprehensive HF management programme on HF patients.
Cecilia Miu‐Ching Chan +13 more
wiley +1 more source
Peripartum cardiomyopathy: diagnosis and management [PDF]
, 2017 No abstract ...
Coats, Caroline J. +5 more
core +1 more source